This company has been marked as potentially delisted and may not be actively trading. Freeline Therapeutics (FRLN) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock FRLN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Freeline to Present New Data on its Gaucher and Parkinson's Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingApril 24, 2024 | globenewswire.comFreeline Therapeutics Stock (NASDAQ:FRLN) Dividends: History, Yield and DatesFebruary 25, 2024 | benzinga.comAcquisition of Freeline by Syncona Becomes EffectiveFebruary 20, 2024 | finance.yahoo.comAcquisition of Freeline by Syncona Becomes EffectiveFebruary 20, 2024 | globenewswire.comFreeline Therapeutics (Nasdaq:FRLN) HeadlineTrading was temporarily halted for "FRLN" at 07:02 PM with a stated reason of "News pending."...February 19, 2024 | marketbeat.comFreeline Therapeutics Shareholders Approve Acquisition by SynconaFebruary 13, 2024 | finanznachrichten.deFreeline Shareholders Approve Acquisition by SynconaFebruary 12, 2024 | finance.yahoo.comFreeline Therapeutics Holdings plc (FRLN)February 9, 2024 | uk.finance.yahoo.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SRC, EAR, PATI, FRLNDecember 1, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Argenx Se (ARGX) and Freeline Therapeutics Holdings (FRLN)November 30, 2023 | markets.businessinsider.comFREELINE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Freeline ...November 29, 2023 | businesswire.comFreeline (FRLN) Shares Rise on Merger Agreement With SynconaNovember 23, 2023 | finance.yahoo.comSyncona Limited to Acquire Freeline TherapeuticsNovember 22, 2023 | finanznachrichten.deFRLN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Freeline Therapeutics Holdings plc Is Fair to ShareholdersNovember 22, 2023 | tmcnet.comFreeline Therapeutics (Nasdaq:FRLN) HeadlineTrading was temporarily halted for "FRLN" at 07:11 AM with a stated reason of "News pending."...November 22, 2023 | marketbeat.comFRLN Freeline Therapeutics Holdings plcNovember 18, 2023 | seekingalpha.comFreeline Therapeutics (Nasdaq:FRLN) HeadlineTrading was temporarily halted for "FRLN" at 10:11 AM with a stated reason of "LULD pause." Trading set to resume at 10:11 AM. November 6, 2023 | marketbeat.comFreeline Therapeutics Holdings PLC ADR FRLNNovember 5, 2023 | morningstar.comMFreeline Therapeutics: Promising Initial Efficacy Data and Potential for High Revenues Justify Buy RatingOctober 28, 2023 | markets.businessinsider.comFreeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease at ESGCT 30th Annual CongressOctober 25, 2023 | finance.yahoo.comHere's Why We're A Bit Worried About Freeline Therapeutics Holdings' (NASDAQ:FRLN) Cash Burn SituationOctober 19, 2023 | finance.yahoo.comWhere Freeline Therapeutics Stands With AnalystsOctober 18, 2023 | markets.businessinsider.comFreeline to Present New Clinical Data for FLT201 in Gaucher Disease in Oral Presentation at Upcoming ESGCT 30th Annual CongressOctober 16, 2023 | finance.yahoo.comFreeline Therapeutics ADRs Rise 14% Following Positive Trial Data on FLT201October 6, 2023 | marketwatch.comPromising Gaucher Disease Trial Results and Potential Parkinson’s Disease Impact Bolster Analyst’s Buy Rating for Freeline Therapeutics HoldingsOctober 5, 2023 | markets.businessinsider.comWhy Is Gene Therapy Player Freeline Therapeutics Stock Trading Higher Today?October 4, 2023 | benzinga.comFreeline Reports Positive Data From First Cohort Of Phase 1/2 GALILEO-1 Trial Of FLT201October 4, 2023 | markets.businessinsider.comFreeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher DiseaseOctober 4, 2023 | finance.yahoo.comH.C. Wainwright Sticks to Their Buy Rating for Freeline Therapeutics Holdings (FRLN)August 17, 2023 | markets.businessinsider.comFreeline Therapeutics Holdings plc (NASDAQ:FRLN) Q2 2023 Earnings Call TranscriptAugust 17, 2023 | finance.yahoo.com4 Analysts Have This to Say About Freeline TherapeuticsAugust 16, 2023 | markets.businessinsider.comQ2 2023 Freeline Therapeutics Holdings PLC Earnings CallAugust 16, 2023 | finance.yahoo.comFreeline Therapeutics GAAP EPS of -$0.23 beats by $3.28, revenue of $0.62MAugust 15, 2023 | seekingalpha.comFreeline Therapeutics Holdings plc: Freeline Reports Second Quarter 2023 Financial Results and Business HighlightsAugust 15, 2023 | finanznachrichten.deFreeline Reports Second Quarter 2023 Financial Results and Business HighlightsAugust 15, 2023 | finance.yahoo.comFreeline Therapeutics's Earnings: A PreviewAugust 14, 2023 | benzinga.comFreeline Therapeutics to Host Second Quarter 2023 Financial Results CallAugust 8, 2023 | finance.yahoo.comFreeline to Host Virtual KOL Event on its Gene Therapy Candidate, FLT201, in Gaucher DiseaseJuly 25, 2023 | finance.yahoo.comFreeline Therapeutics Holdings plcJuly 20, 2023 | thestreet.comFreeline Therapeutics (Nasdaq:FRLN) HeadlineTrading was temporarily halted for "FRLN" at 02:07 PM with a stated reason of "LULD pause." Trading set to resume at 02:07 PM. July 14, 2023 | marketbeat.comFreeline Therapeutics Holdings Shares Halted On Circuit Breaker To The Upside, Up 53.1%July 13, 2023 | benzinga.comEstimating The Fair Value Of Freeline Therapeutics Holdings plc (NASDAQ:FRLN)July 13, 2023 | finance.yahoo.comFreeline Therapeutics (Nasdaq:FRLN) HeadlineTrading was temporarily halted for "FRLN" at 10:07 AM with a stated reason of "LULD pause."...July 12, 2023 | marketbeat.comFreeline Therapeutics (Nasdaq:FRLN) HeadlineTrading was temporarily halted for "FRLN" at 10:07 AM with a stated reason of "LULD pause."...July 12, 2023 | marketbeat.comFreeline Therapeutics (Nasdaq:FRLN) HeadlineTrading was temporarily halted for "FRLN" at 10:07 AM with a stated reason of "LULD pause."...July 12, 2023 | marketbeat.comFreeline Therapeutics (Nasdaq:FRLN) HeadlineTrading was temporarily halted for "FRLN" at 10:07 AM with a stated reason of "LULD pause." Trading set to resume at 10:07 AM. July 12, 2023 | marketbeat.comFreeline Therapeutics (Nasdaq:FRLN) HeadlineTrading was temporarily halted for "FRLN" at 09:07 AM with a stated reason of "LULD pause."...July 12, 2023 | marketbeat.comFreeline Therapeutics (Nasdaq:FRLN) HeadlineTrading was temporarily halted for "FRLN" at 09:07 AM with a stated reason of "LULD pause."...July 12, 2023 | marketbeat.comFreeline Announces First Patient Dosed with Its NovelJune 26, 2023 | tmcnet.comFreeline Announces First Patient Dosed with Its Novel Gene Therapy Candidate for Gaucher Disease and Unveils Research Program in GBA1-linked Parkinson’s DiseaseJune 26, 2023 | finance.yahoo.com Get Freeline Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FRLN and its competitors with MarketBeat's FREE daily newsletter. Email Address FRLN Media Mentions By Week FRLN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FRLN News Sentiment▼0.000.57▲Average Medical News Sentiment FRLN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FRLN Articles This Week▼00▲FRLN Articles Average Week Get Freeline Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FRLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Hyperion DeFi News PHAXIAM Therapeutics News 60 Degrees Pharmaceuticals News Alpha Tau Medical News BriaCell Therapeutics News enGene News Fortress Biotech News GeoVax Labs News Jasper Therapeutics News Lexaria Bioscience News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FRLN) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Freeline Therapeutics Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Freeline Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FRLN Stock Alerts